Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 924

1.

Experimental Candida albicans osteomyelitis: Microbiologic, antigenic, histologic, and 18FDG-PET-CT imaging characteristics in a newly established rabbit model.

Gamaletsou MN, Meletiadis J, Chatziioannou S, Panayiotides IG, Agadakos E, Katsimpoulas M, Kostomitsopoulos N, Petraitis V, Walsh TJ, Sipsas NV; International Consortium of Osteoarticular Mycoses.

Med Mycol. 2019 Feb 7. doi: 10.1093/mmy/myz001. [Epub ahead of print]

PMID:
30753591
2.

Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high risk.

Van Besien K, Bachier-Rodriguez L, Satlin M, Brown MA, Gergis U, Guarneri D, Hsu J, Phillips AA, Mayer SA, Singh AD, Soave R, Rossi A, Small CB, Walsh TJ, Rennert H, Shore TB.

Leuk Lymphoma. 2019 Feb 10:1-4. doi: 10.1080/10428194.2018.1543877. [Epub ahead of print]

PMID:
30741059
3.

The expanding use of matrix-assisted laser desorption/ionization-time of flight mass spectroscopy in the diagnosis of patients with mycotic diseases.

Walsh TJ, McCarthy MW.

Expert Rev Mol Diagn. 2019 Feb 5:1-8. doi: 10.1080/14737159.2019.1574572. [Epub ahead of print]

PMID:
30682890
4.

Invasive Candidiasis in Infants and Children: Recent Advances in Epidemiology, Diagnosis, and Treatment.

Walsh TJ, Katragkou A, Chen T, Salvatore CM, Roilides E.

J Fungi (Basel). 2019 Jan 24;5(1). pii: E11. doi: 10.3390/jof5010011. Review.

5.

Nonmuscle Invasive Bladder Cancer Influences Physical Health Related Quality of Life and Urinary Incontinence.

Brisbane WG, Holt SK, Winters BR, Gore JL, Walsh TJ, Wright JL, Schade GR.

Urology. 2018 Dec 12. pii: S0090-4295(18)31312-8. doi: 10.1016/j.urology.2018.11.038. [Epub ahead of print]

PMID:
30552938
6.

Assessment of focused multivector ultraviolet disinfection with shadowless delivery using 5-point multisided sampling of patient care equipment without manual-chemical disinfection.

Armellino D, Walsh TJ, Petraitis V, Kowalski W.

Am J Infect Control. 2018 Nov 28. pii: S0196-6553(18)30949-0. doi: 10.1016/j.ajic.2018.09.019. [Epub ahead of print]

PMID:
30502110
7.

Candidemia in the cancer patient: diagnosis, treatment, and future directions.

McCarthy MW, Walsh TJ.

Expert Rev Anti Infect Ther. 2018 Nov;16(11):849-854. doi: 10.1080/14787210.2018.1536546. Epub 2018 Oct 16.

PMID:
30322269
8.

Use of secondary contraception following vasectomy: insights from the Pregnancy Risk Assessment Monitoring System, 2007-2011.

Patel DP, Williams L, Warner L, O'Neil ME, Aston K, Carrell DT, Grigorescu V, Jamieson DJ, Gannon JR, Eisenberg ML, Walsh TJ, Hotaling JM.

Transl Androl Urol. 2018 Jul;7(Suppl 3):S264-S270. doi: 10.21037/tau.2018.04.15.

9.

Immunosuppressed Adult Zebrafish Model of Mucormycosis.

Tatara AM, Wurster S, Lockworth CR, Albert ND, Walsh TJ, Mikos AG, Eisenhoffer GT, Kontoyiannis DP.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e00698-18. doi: 10.1128/AAC.00698-18. Print 2018 Nov. No abstract available.

PMID:
30150461
10.

Global guidelines and initiatives from the European Confederation of Medical Mycology to improve patient care and research worldwide: New leadership is about working together.

Hoenigl M, Gangneux JP, Segal E, Alanio A, Chakrabarti A, Chen SC, Govender N, Hagen F, Klimko N, Meis JF, Pasqualotto AC, Seidel D, Walsh TJ, Lagrou K, Lass-Flörl C, Cornely OA; European Confederation of Medical Mycology (ECMM).

Mycoses. 2018 Nov;61(11):885-894. doi: 10.1111/myc.12836. Epub 2018 Aug 28.

PMID:
30086186
11.

Pharmacokinetics and Comprehensive Analysis of the Tissue Distribution of Eravacycline in Rabbits.

Petraitis V, Petraitiene R, Maung BBW, Khan F, Alisauskaite I, Olesky M, Newman J, Mutlib A, Niu X, Satlin M, Singh RS, Derendorf H, Walsh TJ.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e00275-18. doi: 10.1128/AAC.00275-18. Print 2018 Sep.

PMID:
29941646
12.

Testosterone treatment and the risk of aggressive prostate cancer in men with low testosterone levels.

Walsh TJ, Shores MM, Krakauer CA, Forsberg CW, Fox AE, Moore KP, Korpak A, Heckbert SR, Zeliadt SB, Kinsey CE, Thompson ML, Smith NL, Matsumoto AM.

PLoS One. 2018 Jun 22;13(6):e0199194. doi: 10.1371/journal.pone.0199194. eCollection 2018.

13.

Recent Advances in the Treatment of Scedosporiosis and Fusariosis.

McCarthy MW, Katragkou A, Iosifidis E, Roilides E, Walsh TJ.

J Fungi (Basel). 2018 Jun 18;4(2). pii: E73. doi: 10.3390/jof4020073. Review.

14.

Galactomannan antigenemia as a biomarker for therapeutic response of invasive aspergillosis: implications for clinical trial design and patient care.

McCarthy MW, Walsh TJ.

Expert Rev Mol Diagn. 2018 Jul;18(7):601-604. doi: 10.1080/14737159.2018.1488589. Epub 2018 Jun 20.

PMID:
29897826
15.

Pharmacodynamic and Immunomodulatory Effects of Micafungin on Host Responses against Biofilms of Candida parapsilosis in Comparison to Those of Candida albicans.

Simitsopoulou M, Chlichlia K, Kyrpitzi D, Walsh TJ, Roilides E.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00478-18. doi: 10.1128/AAC.00478-18. Print 2018 Aug.

16.

Exposure-Response Analysis of Micafungin in Neonatal Candidiasis: Pooled Analysis of Two Clinical Trials.

Kovanda LL, Walsh TJ, Benjamin DK Jr, Arrieta A, Kaufman DA, Smith PB, Manzoni P, Desai AV, Kaibara A, Bonate PL, Hope WW.

Pediatr Infect Dis J. 2018 Jun;37(6):580-585. doi: 10.1097/INF.0000000000001957.

17.

Stability of isoniazid injection in i.v. solutions.

Lee JH, Moriyama B, Henning SA, Danner RL, Walsh TJ, Penzak SR, Grimes GJ, Potti GK.

Am J Health Syst Pharm. 2018 May 15;75(10):622-626. doi: 10.2146/ajhp170268.

PMID:
29748300
18.

Isavuconazole Concentration in Real-World Practice: Consistency with Results from Clinical Trials.

Andes D, Kovanda L, Desai A, Kitt T, Zhao M, Walsh TJ.

Antimicrob Agents Chemother. 2018 Jun 26;62(7). pii: e00585-18. doi: 10.1128/AAC.00585-18. Print 2018 Jul.

19.

Clinical Pharmacokinetics and Pharmacodynamics of Isavuconazole.

McCarthy MW, Moriyama B, Petraitiene R, Walsh TJ, Petraitis V.

Clin Pharmacokinet. 2018 Dec;57(12):1483-1491. doi: 10.1007/s40262-018-0673-2. Review.

PMID:
29725999
20.

Colonization With Levofloxacin-resistant Extended-spectrum β-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients.

Satlin MJ, Chavda KD, Baker TM, Chen L, Shashkina E, Soave R, Small CB, Jacobs SE, Shore TB, van Besien K, Westblade LF, Schuetz AN, Fowler VG Jr, Jenkins SG, Walsh TJ, Kreiswirth BN.

Clin Infect Dis. 2018 Nov 13;67(11):1720-1728. doi: 10.1093/cid/ciy363.

PMID:
29701766
21.

The rise of hospitalists: an opportunity for infectious diseases investigators.

McCarthy MW, Walsh TJ.

Expert Rev Anti Infect Ther. 2018 May;16(5):385-389. doi: 10.1080/14787210.2018.1462158. Epub 2018 Apr 11.

PMID:
29620478
22.

A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis.

Benjamin DK Jr, Kaufman DA, Hope WW, Smith PB, Arrieta A, Manzoni P, Kovanda LL, Lademacher C, Isaacson B, Jednachowski D, Wu C, Kaibara A, Walsh TJ.

Pediatr Infect Dis J. 2018 Oct;37(10):992-998. doi: 10.1097/INF.0000000000001996.

23.

Erratum for Drusano et al., "Dilution Factor of Quantitative Bacterial Cultures Obtained by Bronchoalveolar Lavage in Patients with Ventilator-Associated Bacterial Pneumonia".

Drusano GL, Corrado ML, Girardi G, Ellis-Grosse EJ, Wunderink RG, Donnelly H, Leeper KV, Brown M, Malek T, Hite RD, Ferrari M, Djureinovic D, Kollef MH, Mayfield L, Doyle A, Chastre J, Combes A, Walsh TJ, Dorizas K, Alnuaimat H, Morgan BE, Rello J, Mazo CA, Jones RN, Flamm RK, Woosley L, Ambrose PG, Bhavnani S, Rubino CM, Bulik CC, Louie A, Vicchiarelli M, Berman C.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e00198-18. doi: 10.1128/AAC.00198-18. Print 2018 Apr. No abstract available.

24.

Evaluation of Vasectomy Trends in the United States.

Ostrowski KA, Holt SK, Haynes B, Davies BJ, Fuchs EF, Walsh TJ.

Urology. 2018 Aug;118:76-79. doi: 10.1016/j.urology.2018.03.016. Epub 2018 Mar 22.

PMID:
29578040
25.

Isolated cutaneous mucormycosis in a pediatric renal transplant recipient.

Downie ML, Alghounaim M, Davidge KM, Yau Y, Walsh TJ, Pope E, Somers GR, Waters V, Robinson LA.

Pediatr Transplant. 2018 Jun;22(4):e13172. doi: 10.1111/petr.13172. Epub 2018 Mar 23.

PMID:
29569805
26.

Amino Acid Metabolism and Transport Mechanisms as Potential Antifungal Targets.

McCarthy MW, Walsh TJ.

Int J Mol Sci. 2018 Mar 19;19(3). pii: E909. doi: 10.3390/ijms19030909. Review.

27.

Polymyxin B and fosfomycin thwart KPC-producing Klebsiella pneumoniae in the hollow-fibre infection model.

Bulman ZP, Zhao M, Satlin MJ, Chen L, Kreiswirth BN, Walsh TJ, Nation RL, Li J, Tsuji BT.

Int J Antimicrob Agents. 2018 Jul;52(1):114-118. doi: 10.1016/j.ijantimicag.2018.02.010. Epub 2018 Feb 24.

PMID:
29486233
28.

Invasive Fungal Infections in Patients with Hematological Malignancies: Emergence of Resistant Pathogens and New Antifungal Therapies.

Gamaletsou MN, Walsh TJ, Sipsas NV.

Turk J Haematol. 2018 Mar 1;35(1):1-11. doi: 10.4274/tjh.2018.0007. Epub 2018 Feb 2. Review.

29.

Mycobacterial spindle cell pseudotumour: epidemiology and clinical outcomes.

Sfeir MM, Schuetz A, Van Besien K, Borczuk AC, Soave R, Jenkins SG, Walsh TJ, Small CB.

J Clin Pathol. 2018 Jul;71(7):626-630. doi: 10.1136/jclinpath-2017-204777. Epub 2018 Jan 24. Review.

PMID:
29367301
30.

Meropenem/vaborbactam fixed combination for the treatment of patients with complicated urinary tract infections.

McCarthy MW, Walsh TJ.

Drugs Today (Barc). 2017 Oct;53(10):521-530. doi: 10.1358/dot.2017.53.10.2721815. Review.

PMID:
29286054
31.

Containment strategies to address the expanding threat of multidrug-resistant Candida auris.

McCarthy MW, Walsh TJ.

Expert Rev Anti Infect Ther. 2017 Dec;15(12):1095-1099. doi: 10.1080/14787210.2017.1402678. Epub 2017 Nov 13. Review.

PMID:
29110544
32.

Clinical utility of sperm DNA fragmentation testing: practice recommendations based on clinical scenarios.

Raheem OA, Ana M, Urol M, Walsh TJ.

Transl Androl Urol. 2017 Sep;6(Suppl 4):S322-S323. doi: 10.21037/tau.2017.08.14. No abstract available.

33.

Dilution Factor of Quantitative Bacterial Cultures Obtained by Bronchoalveolar Lavage in Patients with Ventilator-Associated Bacterial Pneumonia.

Drusano GL, Corrado ML, Girardi G, Ellis-Grosse EJ, Wunderink RG, Donnelly H, Leeper KV, Brown M, Malek T, Hite RD, Ferrari M, Djureinovic D, Kollef MH, Mayfield L, Doyle A, Chastre J, Combes A, Walsh TJ, Dorizas K, Alnuaimat H, Morgan BE, Rello J, Mazo CA, Jones RN, Flamm RK, Woosley L, Ambrose PG, Bhavnani S, Rubino CM, Bulik CC, Louie A, Vicchiarelli M, Berman C.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e01323-17. doi: 10.1128/AAC.01323-17. Print 2018 Jan. Erratum in: Antimicrob Agents Chemother. 2018 Mar 27;62(4):.

34.

Successful Treatment of Invasive Conidiobolus Infection During Therapy for Acute Lymphoblastic Leukemia.

Erker C, Huppler AR, Walsh TJ, McCormick ME, Suchi M, Bhatt NS, Kehl SC, Southwood J, Harker-Murray P.

J Pediatr Hematol Oncol. 2018 Oct;40(7):e446-e449. doi: 10.1097/MPH.0000000000000985.

PMID:
28991126
35.

Diagnostic Imaging and Invasive Fungal Diseases in Children.

Katragkou A, Fisher BT, Groll AH, Roilides E, Walsh TJ.

J Pediatric Infect Dis Soc. 2017 Sep 1;6(suppl_1):S22-S31. doi: 10.1093/jpids/pix055. Review.

PMID:
28927203
36.

Role of Molecular Biomarkers in the Diagnosis of Invasive Fungal Diseases in Children.

Huppler AR, Fisher BT, Lehrnbecher T, Walsh TJ, Steinbach WJ.

J Pediatric Infect Dis Soc. 2017 Sep 1;6(suppl_1):S32-S44. doi: 10.1093/jpids/pix054. Review.

37.

Novel Agents and Drug Targets to Meet the Challenges of Resistant Fungi.

McCarthy MW, Kontoyiannis DP, Cornely OA, Perfect JR, Walsh TJ.

J Infect Dis. 2017 Aug 15;216(suppl_3):S474-S483. doi: 10.1093/infdis/jix130. Review.

PMID:
28911042
38.

Future Research Priorities in Fungal Resistance.

McCarthy MW, Denning DW, Walsh TJ.

J Infect Dis. 2017 Aug 15;216(suppl_3):S484-S492. doi: 10.1093/infdis/jix103.

PMID:
28911040
39.

Fungal Infections of the Central Nervous System in Children.

McCarthy MW, Kalasauskas D, Petraitis V, Petraitiene R, Walsh TJ.

J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):e123-e133. doi: 10.1093/jpids/pix059. Review.

PMID:
28903523
40.
41.

Peripheral rapid infusion via the corpus cavernosum: An investigation of penile vascular access flow rates.

Osbun N, Rogers MJ, Walsh TJ, Yang C.

J Trauma Acute Care Surg. 2017 Nov;83(5):975-977. doi: 10.1097/TA.0000000000001668. No abstract available.

PMID:
28787377
42.

Response to "Impact of CYP3A4 Genotype on Voriconazole Exposure: New Insights Into the Contribution of CYP3A4*22 to Metabolism of Voriconazole".

Walsh TJ, Moriyama B, Penzak SR, Klein TE, Caudle KE.

Clin Pharmacol Ther. 2018 Feb;103(2):187. doi: 10.1002/cpt.811. Epub 2017 Nov 16. No abstract available.

PMID:
28786218
43.

Avibactam Restores the Susceptibility of Clinical Isolates of Stenotrophomonas maltophilia to Aztreonam.

Mojica MF, Papp-Wallace KM, Taracila MA, Barnes MD, Rutter JD, Jacobs MR, LiPuma JJ, Walsh TJ, Vila AJ, Bonomo RA.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e00777-17. doi: 10.1128/AAC.00777-17. Print 2017 Oct.

44.

Polymyxin Combinations Combat Escherichia coli Harboring mcr-1 and blaNDM-5: Preparation for a Postantibiotic Era.

Bulman ZP, Chen L, Walsh TJ, Satlin MJ, Qian Y, Bulitta JB, Peloquin CA, Holden PN, Nation RL, Li J, Kreiswirth BN, Tsuji BT.

MBio. 2017 Jul 25;8(4). pii: e00540-17. doi: 10.1128/mBio.00540-17.

45.

Combination Therapy with Isavuconazole and Micafungin for Treatment of Experimental Invasive Pulmonary Aspergillosis.

Petraitis V, Petraitiene R, McCarthy MW, Kovanda LL, Zaw MH, Hussain K, Shaikh N, Maung BBW, Sekhon NK, Hope WW, Walsh TJ.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00305-17. doi: 10.1128/AAC.00305-17. Print 2017 Sep.

46.

Male Infertility and Risk of Cancer.

Rogers MJ, Walsh TJ.

Semin Reprod Med. 2017 May;35(3):298-303. doi: 10.1055/s-0037-1603583. Epub 2017 Jun 28. Review. No abstract available.

PMID:
28658714
47.

Computational method allowing Hydrogen-Deuterium Exchange Mass Spectrometry at single amide Resolution.

Gessner C, Steinchen W, Bédard S, J Skinner J, Woods VL, Walsh TJ, Bange G, Pantazatos DP.

Sci Rep. 2017 Jun 19;7(1):3789. doi: 10.1038/s41598-017-03922-3.

48.

Drugs currently under investigation for the treatment of invasive candidiasis.

McCarthy MW, Walsh TJ.

Expert Opin Investig Drugs. 2017 Jul;26(7):825-831. doi: 10.1080/13543784.2017.1341488. Review.

PMID:
28617137
49.

Special considerations for the diagnosis and treatment of invasive pulmonary aspergillosis.

McCarthy MW, Walsh TJ.

Expert Rev Respir Med. 2017 Sep;11(9):739-748. doi: 10.1080/17476348.2017.1340835. Epub 2017 Jun 21. Review.

PMID:
28595486
50.

Endpoint Assessment in Rabbit Models of Invasive Pulmonary Aspergillosis and Mucormycosis.

Petraitis V, Petraitiene R, Hope WW, Walsh TJ.

Methods Mol Biol. 2017;1625:259-277. doi: 10.1007/978-1-4939-7104-6_18.

PMID:
28584996

Supplemental Content

Loading ...
Support Center